#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma Subdural haematoma Endometrial cancer Medulloblastoma Hereditary haemorrhagic telangiectasia Drug eruption Thromboangiitis obliterans Kawasaki's disease Neurodegenerative disorder Vascular malformation Bulbospinal muscular atrophy congenital Precursor T-lymphoblastic lymphoma/leukaemia recurrent Anti-HLA antibody test positive Liver abscess Breast cancer More trials…

    Learn about Rare Diseases

    Angiosarcoma – Trials in Disease Encephalitis autoimmune – Treatment Primary biliary cholangitis – Treatment Thrombotic thrombocytopenic purpura – Trials in Disease Adrenogenital syndrome Uterine leiomyosarcoma – Life with Disease Progressive multifocal leukoencephalopathy – Basic Information Primary mediastinal large B-cell lymphoma – Basic Information Mucous membrane pemphigoid – Trials in Disease Hereditary ataxia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Specific Nucleic Acid Sna-Veru Rintatolimod Phenazone At-1501 Glucocorticoids Incb000928 Bms-986340 Propranolol Hydrochloride IMELASOMERAN Fedratinib Vusolimogene Oderparepvec Inupadenant Lenacapavir Sodium FRUQUINTINIB Phleum Pratense Pollen Extract Nitrogen Glucose Berzosertib Latozinemab BI 456906 More therapies…

    Learn about Your Condition

    Non-obstructive cardiomyopathy Progressive supranuclear palsy Craniocerebral injury Dilated cardiomyopathy Acute respiratory failure Psoriasis Colorectal adenocarcinoma Piriformis syndrome Neuropathic arthropathy Diverticulitis HER2 negative breast cancer Iron deficiency VEXAS syndrome Otitis media Procedural headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer

  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Futibatinib
    • Calcium Folinate Pentahydrate
    • Tislelizumab
    Germany

  • Study of Telisotuzumab Adizutecan for Adults with Colorectal Cancer Who Have Positive Circulating Tumor DNA After Treatment but No Visible Cancer on Scans

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer
    Belgium Denmark Italy Spain

  • Study on the Safety of PD L 506 for Patients with First-Time Colorectal Cancer and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany

  • Study on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Volrustomig
    • Bevacizumab
    • Calcium Folinate
    France Germany Italy The Netherlands Spain

  • Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Amivantamab
    • Bevacizumab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    Finland
Previous Page
1 2 3 4 5 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!